Malignant Urinary System Neoplasm — Trials

Malignant Urinary System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,853 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 888
Recruiting: 467
Ph III recruiting: 52
Growth YoY: +13.3%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (556)

clinicaltrialsPublishedShowing 451–500 of 606 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00515697	A Study of Ramucirumab in Participants With Metastatic Renal Cell Carcinoma	completed	Phase 2	39	Eli Lilly and CompanyINDUSTRY	1	Jun 18, 2014	clinicaltrials
NCT01163552	Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity	completed	Phase 2	5	St. Luke's-Roosevelt Hospital CenterOTHER	1	Jun 13, 2014	clinicaltrials